Skip to main content
Clinical Trials/NCT02664701
NCT02664701
Active, Not Recruiting
N/A

Cognitive Behavioural Group Therapy Versus Individual Supportive Therapy for the Prevention of Repeat Suicide Attempts: a Multicentre, Assessor-blinded, 2-parallel-group, Randomised, Superiority Trial

Centre Hospitalier Universitaire de Nīmes18 sites in 1 country240 target enrollmentOctober 17, 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
Suicidal Ideation
Sponsor
Centre Hospitalier Universitaire de Nīmes
Enrollment
240
Locations
18
Primary Endpoint
The primary clinical endpoint is the duration (in days) of a suicide reattempt-free follow-up period
Status
Active, Not Recruiting
Last Updated
8 months ago

Overview

Brief Summary

The primary objective of this study is to evaluate the efficacy of a program of 6 sessions of Cognitive Behavioural Group Therapy (CBGT) (as compared to 6 sessions of Individual Supportive Therapy (IST)) designed for preventing repeat suicide attempts at 12 months post-psychotherapy in adults admitted to inpatient care for suicide attempts.

Detailed Description

The secondary objectives of this study are to assess the efficacy of CBGT on: A. parameters describing the incidence of suicide and repeat suicide attempts, as well as suicide re-attempt free follow-up time, B. long-term changes in suicidal ideation, C. long-term changes in psychiatric symptoms (depression, hope for the future, hospitalization).

Registry
clinicaltrials.gov
Start Date
October 17, 2017
End Date
November 1, 2025
Last Updated
8 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Centre Hospitalier Universitaire de Nīmes
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • The patient has been correctly informed
  • The patient must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • French speaking adults (18 years or older) freely hospitalized (in centres or via emergency services) for prevention of suicide and who have a medium or high suicide risk score according to a Mini International Neuropsychiatric Interview structured interview
  • Presence of suicidal ideation according to the Beck Suicide Ideation Scale (score \> 3)
  • Prior (or recent) suicide attempt within the last three month
  • The patient is able to understand the study and capable of giving his/her informed consent
  • The patient is available during the weekly time slots proposed by the investigator

Exclusion Criteria

  • The patient is participating in another study that may interfere with the results or conclusions of this study
  • Within the past three months, the patient has participated in another study that may interfere with the results or conclusions of this study
  • The patient is in an exclusion period determined by a previous study
  • The patient is under judicial protection, or is an adult under guardianship
  • The patient refuses to sign the consent, or it is impossible to correctly inform the patient
  • Emergency situations preventing proper study conduct
  • History of schizophrenia or other psychotic troubles
  • Presence of psychotic symptoms at initial interview
  • Serious cognitive impairment
  • Medical incapacity to participate

Outcomes

Primary Outcomes

The primary clinical endpoint is the duration (in days) of a suicide reattempt-free follow-up period

Time Frame: 12 months

Secondary Outcomes

  • The Columbia suicide severity rating scale (C-SSRS)(12 months)
  • Number of suicide re-attempts during the follow-up period.(12 months)
  • Completed suicide (yes/no)(12 months)
  • Beck Suicide Ideation Scale (BSSI)(12 months)
  • Beck Depression Inventory-II (BDI-II)(12 months)
  • Beck Hopelessness Scale (BHS)(12 months)
  • Cumulative days of hospitalization(12 months)

Study Sites (18)

Loading locations...

Similar Trials